© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
The role of antibody drug conjugate DS-8201a (trastuzumab deruxtecan) in the treatment of HER2-positive metastatic breast cancer and an overview of the DESTINY-Breast02 and DESTINY-Breast03 trials.
I Never Expected to Be the Caregiver with Cancer
Spring Into the Season With New Recipes
How I Wish You Were Still Here to See it All
Kathy Ireland Joins the National Pediatric Cancer Foundation’s ‘Team 43’ to Raise Funds and Awareness